(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(-0.73%) $83.24
(-1.16%) $1.619
(-0.15%) $2 343.70
(-0.18%) $27.49
(0.40%) $925.80
(-0.11%) $0.934
(-0.10%) $11.01
(-0.17%) $0.799
(0.00%) $92.17
4.30% HKD 35.20
Live Chart Being Loaded With Signals
WuXi AppTec Co., Ltd., an investment holding company, provides research, development, and manufacturing services to discover, develop, and manufacture small molecule drugs, and cell and gene therapies in the People's Republic of China, rest of Asia, the United States, Europe, and internationally...
Stats | |
---|---|
Dagens volum | 9.16M |
Gjennomsnittsvolum | 10.52M |
Markedsverdi | 125.85B |
EPS | HKD0.940 ( 2023-10-31 ) |
Last Dividend | HKD0.989 ( 2023-06-05 ) |
Next Dividend | HKD0 ( N/A ) |
P/E | 10.06 |
ATR14 | HKD0.0650 (0.18%) |
Volum Korrelasjon
WuXi AppTec Co., Ltd. Korrelasjon
10 Mest positive korrelasjoner |
---|
10 Mest negative korrelasjoner |
---|
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
WuXi AppTec Co., Ltd. Korrelasjon - Valuta/Råvare
WuXi AppTec Co., Ltd. Økonomi
Annual | 2023 |
Omsetning: | HKD40.34B |
Bruttogevinst: | HKD16.61B (41.18 %) |
EPS: | HKD3.27 |
FY | 2023 |
Omsetning: | HKD40.34B |
Bruttogevinst: | HKD16.61B (41.18 %) |
EPS: | HKD3.27 |
FY | 2022 |
Omsetning: | HKD39.35B |
Bruttogevinst: | HKD14.68B (37.30 %) |
EPS: | HKD3.15 |
FY | 2021 |
Omsetning: | HKD22.90B |
Bruttogevinst: | HKD8.31B (36.28 %) |
EPS: | HKD1.820 |
Financial Reports:
No articles found.
WuXi AppTec Co., Ltd. Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0.989 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | HKD0.281 | 2019-06-17 |
Last Dividend | HKD0.989 | 2023-06-05 |
Next Dividend | HKD0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 5 | -- |
Total Paid Out | HKD2.45 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.55 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 7.38 | |
Div. Directional Score | 10.00 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Furthermore, its high Dividend Growth Potential Score (DGPS) signals potential dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
2343.HK | Ex Dividend Junior | 2023-08-11 | Annually | 0 | 0.00% | |
1316.HK | Ex Dividend Junior | 2023-06-23 | Annually | 0 | 0.00% | |
0382.HK | Ex Dividend Knight | 2023-05-10 | Semi-Annually | 0 | 0.00% | |
6190.HK | Ex Dividend Junior | 2023-07-03 | Annually | 0 | 0.00% | |
1881.HK | Ex Dividend Knight | 2023-05-11 | Semi-Annually | 0 | 0.00% | |
0906.HK | Ex Dividend Junior | 2023-09-04 | Semi-Annually | 0 | 0.00% | |
0038.HK | Ex Dividend Junior | 2023-06-08 | Sporadic | 0 | 0.00% | |
2779.HK | Ex Dividend Junior | 2023-06-20 | Annually | 0 | 0.00% | |
1451.HK | Ex Dividend Junior | 2023-06-05 | Insufficient data to determine frequency | 0 | 0.00% | |
0535.HK | Ex Dividend Junior | 2023-07-14 | Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.238 | 1.500 | 5.24 | 7.86 | [0 - 0.5] |
returnOnAssetsTTM | 0.130 | 1.200 | 5.65 | 6.78 | [0 - 0.3] |
returnOnEquityTTM | 0.187 | 1.500 | 9.04 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.287 | -1.000 | 7.13 | -7.13 | [0 - 1] |
currentRatioTTM | 2.06 | 0.800 | 4.69 | 3.75 | [1 - 3] |
quickRatioTTM | 1.610 | 0.800 | 5.24 | 4.19 | [0.8 - 2.5] |
cashRatioTTM | 0.933 | 1.500 | 5.93 | 8.89 | [0.2 - 2] |
debtRatioTTM | 0.0780 | -1.500 | 8.70 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 61.33 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 4.20 | 2.00 | 8.60 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 2.35 | 2.00 | 8.83 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.104 | -1.500 | 9.58 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.412 | 1.000 | 6.47 | 6.47 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.294 | 1.000 | 6.11 | 6.11 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 2.18 | 1.000 | 10.00 | 10.00 | [0.2 - 2] |
assetTurnoverTTM | 0.548 | 0.800 | 9.68 | 7.75 | [0.5 - 2] |
Total Score | 12.79 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 10.12 | 1.000 | 9.08 | 0 | [1 - 100] |
returnOnEquityTTM | 0.187 | 2.50 | 9.38 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 2.35 | 2.00 | 9.22 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 3.04 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 4.20 | 2.00 | 8.60 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.287 | 1.500 | 7.13 | -7.13 | [0 - 1] |
pegRatioTTM | 0.503 | 1.500 | 9.98 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.311 | 1.000 | 4.74 | 0 | [0.1 - 0.5] |
Total Score | 7.38 |
WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd., an investment holding company, provides research, development, and manufacturing services to discover, develop, and manufacture small molecule drugs, and cell and gene therapies in the People's Republic of China, rest of Asia, the United States, Europe, and internationally. The company operates through six segments: WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and Others. It offers contract research, development, and manufacturing organization services for new drug development from discovery to commercial covering various categories for various synthetic molecular modalities, including small molecules, oligonucleotides, peptides, and complex conjugates; and biology services and solutions that support stand-alone and integrated projects from target discovery to candidate selection and into the clinic. The company also provides seamless drug and medical device testing services from preclinical testing to clinical trials; an integrated end-to-end solution to accelerate time to market for cell and gene therapies; drug discovery services to pharmaceutical and biotech customers; and clinical research services. WuXi AppTec Co., Ltd. was founded in 2000 and is headquartered in Shanghai, the People's Republic of China.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.